Mumbai, Maharashtra, India, July 2025 — Lupin has announced the appointment of Anil V Kaushal as the Chief Executive Officer of LupinLife Consumer Healthcare, a newly carved-out subsidiary focused on the self-care segment in India. This strategic move reflects Lupin’s intent to unlock greater value from its consumer health portfolio by giving it an independent structure under seasoned leadership.
Anil, who has been with Lupin since 2014, has played a pivotal role in conceptualizing and building the consumer health business from the ground up. Under his leadership, the division has grown into a recognized name in the OTC space, backed by strong distribution networks, brand-building initiatives, and product innovation. With his new mandate as CEO of LupinLife Consumer Healthcare, Anil will spearhead the company’s next phase of growth, focused on agility, purpose-led branding, and deeper consumer engagement.
Prior to Lupin, Anil held the role of Director – Consumer Healthcare (Global Business) at Dr. Reddy’s Laboratories, where he led non-India markets for consumer health. At Dabur India Limited, he served as Head of OTC Business, managing major product lines such as Lal Tail, Honitus, and Shilajit Gold, and driving profitability and brand success. He also led marketing at Rich Products Corporation, where he built award-winning food and dessert brands, and worked at Pfizer Ltd as Senior Product Manager, managing iconic brands like Listerine and Benadryl.
Anil began his career with Kopran Limited, launching brands in the Rx and OTC segments. His educational credentials include a Bachelor’s in Pharmaceutical Sciences, a PGDM from IILM, and an executive program in Leadership and Management from Cornell University. Known for his multidimensional personality, Anil is also a trained pilot, a performing arts enthusiast, and a vocal proponent of purpose-driven consumer brands.
With Anil at the helm, LupinLife Consumer Healthcare is expected to focus on innovation, category expansion, and a renewed customer-first approach in India’s rapidly growing health and wellness market.
Lupin Limited is a global pharmaceutical company headquartered in Mumbai, India, operating in over 100 countries. With a strong presence in both developed and emerging markets, Lupin offers a wide portfolio including branded and generic formulations, biotechnology products, and APIs. The company has 15 manufacturing facilities, 7 R&D centers, and employs over 23,000 professionals worldwide. Through its subsidiaries—Lupin Diagnostics, Lupin Digital Health, Lupin Manufacturing Solutions, and now LupinLife Consumer Healthcare—Lupin remains committed to improving global health outcomes.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
